XML 54 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2021   525      
Beginning balance at Dec. 31, 2021 $ 11,991 $ 5 $ 27 $ 11,922 $ 37
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 563     563  
Other comprehensive income (loss)         (56)
Other comprehensive income (loss) (56)        
Common stock issued, stock-based compensation plans (in shares)   1      
Common stock issued, stock-based compensation plans - value 31   31    
Stock-based compensation expense 56   56    
Repurchases of common stock (in shares)   (5)      
Repurchases of common stock (470)   (83) (387)  
Dividends declared (142)     (142)  
Ending balance (in shares) at Mar. 31, 2022   521      
Ending balance at Mar. 31, 2022 11,973 $ 5 31 11,956 (19)
Beginning balance (in shares) at Dec. 31, 2021   525      
Beginning balance at Dec. 31, 2021 11,991 $ 5 27 11,922 37
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 1,140        
Other comprehensive income (loss) (306)       (306)
Ending balance (in shares) at Jun. 30, 2022   518      
Ending balance at Jun. 30, 2022 11,950 $ 5 21 12,193 (269)
Beginning balance (in shares) at Mar. 31, 2022   521      
Beginning balance at Mar. 31, 2022 11,973 $ 5 31 11,956 (19)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 577     577  
Other comprehensive income (loss) (250)       (250)
Other comprehensive income (loss) (250)        
Common stock issued, stock-based compensation plans (in shares)   1      
Common stock issued, stock-based compensation plans - value 21   21    
Stock-based compensation expense 89   89    
Repurchases of common stock (in shares)   (4)      
Repurchases of common stock (318)   (120) (198)  
Dividends declared (142)     (142)  
Ending balance (in shares) at Jun. 30, 2022   518      
Ending balance at Jun. 30, 2022 $ 11,950 $ 5 21 12,193 (269)
Beginning balance (in shares) at Dec. 31, 2022 509 509      
Beginning balance at Dec. 31, 2022 $ 12,309 $ 5 15 12,588 (299)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 580     580  
Other comprehensive income (loss)         77
Other comprehensive income (loss) 77        
Common stock issued, stock-based compensation plans (in shares)   2      
Common stock issued, stock-based compensation plans - value 23   23    
Stock-based compensation expense 44   44    
Repurchases of common stock (in shares)   (4)      
Repurchases of common stock (223)   (60) (163)  
Dividends declared (149)     (149)  
Ending balance (in shares) at Mar. 31, 2023   507      
Ending balance at Mar. 31, 2023 $ 12,661 $ 5 22 12,856 (222)
Beginning balance (in shares) at Dec. 31, 2022 509 509      
Beginning balance at Dec. 31, 2022 $ 12,309 $ 5 15 12,588 (299)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 1,043        
Other comprehensive income (loss) $ 158       158
Ending balance (in shares) at Jun. 30, 2023 505 505      
Ending balance at Jun. 30, 2023 $ 12,903 $ 5 17 13,022 (141)
Beginning balance (in shares) at Mar. 31, 2023   507      
Beginning balance at Mar. 31, 2023 12,661 $ 5 22 12,856 (222)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 463        
Other comprehensive income (loss) 81       81
Other comprehensive income (loss) 81        
Common stock issued, stock-based compensation plans (in shares)   1      
Common stock issued, stock-based compensation plans - value 18   18    
Stock-based compensation expense 42   42    
Repurchases of common stock (in shares)   (3)      
Repurchases of common stock (215)   (65) (150)  
Dividends declared $ (147)     (147)  
Ending balance (in shares) at Jun. 30, 2023 505 505      
Ending balance at Jun. 30, 2023 $ 12,903 $ 5 $ 17 $ 13,022 $ (141)